Electronic Prescribing and Electronic Transmission of Discharge Medication Lists

Medication Errors Clinical Trial

Official title:

Electronic Prescribing and Electronic Transmission of Discharge Medication Lists to Improve Ambulatory Medication Safety

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00603070
• Other study ID #: R18HS017029-01
• Status: Completed
• Phase: N/A
• First received: January 15, 2008
• Last updated: February 17, 2012
• Start date: March 2008
• Est. completion date: March 2011

Study information

• Verified date: February 2012
• Source: Weill Medical College of Cornell University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is twofold:

1. to measure the effects of transitioning from one electronic prescribing system to another in the ambulatory setting on medication errors and human-computer interactions

2. to evaluate the impact of electronic transmission of discharge medication lists to the ambulatory setting on medication discrepancies and adverse drug events

Recruitment information / eligibility

• Status: Completed
• Enrollment: 130
• Est. completion date: March 2011
• Est. primary completion date: March 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Physicians or nurse practitioners with at least 4 clinic sessions per week

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Medication Errors

Intervention

Other:
• E-prescribing system
Transition from home-grown to vendor-based ambulatory e-prescribing systems
• Electronic transmission of medication discharge lists
Patient discharge medication lists will be transmitted upon discharge from their inpatient medical record to their outpatient medical record and their outpatient provider will be notified of this transmission.

Locations

Country	Name	City	State
United States	Weill Cornell Internal Medicine Associates	New York	New York

Sponsors (5)

Lead Sponsor	Collaborator
Weill Medical College of Cornell University	Agency for Healthcare Research and Quality (AHRQ), Columbia University, New York Presbyterian Hospital, Oregon Health and Science University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prescription medication errors		2 weeks prior, 3 months, 1 year after intervention and 2 years after intervention	Yes
Primary	Medication discrepancies (as detected on a comparison between inpatient and outpatient medical records)		30 days after patient is discharged from hospital	Yes
Primary	Patient adverse drug events (as determined by patient telephone interview and medical record review)		30 days after patient hospital discharge	Yes
Secondary	Human-Computer interactions as measured by physician interview and direct observation of physician work		3 months after intervention	No